Advertisement

Topics

Xofigo (radium-223 dichloride) - Biotech, Pharma and Life Science Channel

01:23 EDT 24th June 2017 | BioPortfolio

New treatment for castration-resistant prostate cancer (CRPC) patients with bone metastases.

Xofigo shown in a pivotal phase III trial to significantly improve overall survival.

Xofigo® with the active ingredient radium 223 dichloride (radium 223) is an alpha particle-emitting radioactive therapeutic agent with an anti-tumor effect on bone metastases. Radium 223 mimics calcium and forms complexes with the bone mineral hydroxyapatite at areas of increased bone turnover, such as bone metastases. The high linear energy transfer of alpha emitters may cause double-strand DNA breaks in adjacent cells, resulting in an anti-tumor effect on bone metastases. The alpha particle range from radium 223 is less than 100 micrometers, which may limit the damage to the surrounding normal tissue.

The US Food and Drug Administration (FDA) has approved Xofigo® (radium-223 dichloride) injection for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastatic disease. Xofigo is the first alpha particle-emitting radioactive therapeutic agent approved by the FDA, that has demonstrated improvement in overall survival (OS) and delay in time to first symptomatic skeletal event (SSE) compared to placebo, as shown in the pivotal phase III ALSYMPCA trial.

The commercial production of Xofigo is underway, and first doses are expected to be ready for patient treatment within a few weeks. Bayer has worldwide exclusive marketing rights for Xofigo. Algeta US, LLC and Bayer Healthcare will co-promote the product in the US.

Source: http://www.algeta.com/news/

Xofigo® is a registered trademark of Bayer.

News Articles [19 Associated News Articles listed on BioPortfolio]

Paraquat Dichloride Market: By Application Herbicide, Desiccant, Defoliant, Plant Growth Regulator, Others By Geography Europe, Asia Pacific, North America, Rest of the WorldForecast 20162021 [Updated: 29022016] Prices from USD $5250

Paraquat dichloride is organic in nature and is a chloride salt of paraquat. Paraquat dichloride also known as 1, 1 dimethyl4, 4'bipyridinium is classified as a viologen, which is a family of redox a...

Prostate Cancer Therapeutics Market is expected to reach USD 12.0 billion by 2025

LONDON, June 20, 2017 /PRNewswire/ -- Highlights ·         The global prostate cancer therapeutics market is expected to reach USD 12.0 billion by 2025, ac...

Chlorine Market: By Production Mercury, Membrane Cell, Diaphragm Others, By Application PVC, C1/C2, Chemicals, Chlorinated Intermediaries, Isocyanates, Propylene Oxide, Pulp Paper, Water Treatment Others By EndUser GeographyForecast 20162021 [Updated:

Chlorine is greenishyellow gas with a strong pungent smell. Chlorine is one of the most important commercially available chemical which finds its applications in all major industries. Naturally chlori...

Global Thionyl Dichloride Market Research Report Forecast 2017 to 2021 [Updated: 10052017] Prices from USD $2800

The Global Thionyl Dichloride Market Research Report Forecast 20172021 is a valuable source of insightful data for business strategists. It provides the Thionyl Dichloride industry overview with growt...

Prostate Cancer Therapeutics Market Size Worth $12.0 Billion by 2025: Grand View Research, Inc.

SAN FRANCISCO, June 13, 2017 /PRNewswire/ -- The global prostate cancer therapeutics market is expected to reach USD 12.0 billion by 2025, according to a new report by Grand View Researc...

Radium, recruitment and emergency beds: the work of the Fund in World War II

Nikki Smiton The King’s Fund is celebrating its 120th anniversary over the course of 2017. In the fifth of a series of blogs looking back at our h...

Chemical Intermediates Market: By Type Reagents, Solvents, Building blocks, Protective groups and others,; By application Pharmaceutical, Petrochemical, Lubricants, Agriculture, and others, By Form and By Geography Forecast 2017 2022 [Updated: 06012015]

Chemical intermediate is an essential element for the production of basic everyday requirements such as textiles, soaps, polyvinyl chloride PVC and other plastics. These intermediate chemicals exist i...

Diethylenetriamine Market: By Industry Adhesive and Sealant industry, Paper industry, Water treatment industry, Oil industry, Automotive industry, Agro and textile chemical industry, By Application Corrosion inhibitors and antiscaling agents, Surface acti

Diethylenetriamine or DETA is a member of the ethyleneamine family and consist of both primary and secondary amine functional group. DETA is a hygroscopic liquid with characteristic ammonialike odor. ...

Accepted Abstract by ICML With Updated Results From Phase 1/2 Trial of Betalutin® in NHL is Now Available On-line

OSLO, Norway, June 7, 2017 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces that an abstract reporting updated results from the ongoing LYMRIT 37-01 Phase 1/2 clinical study of Betaluti...

Bayer to Highlight Oncology Franchise Research at ASCO 2017

WHIPPANY, N.J., May 17, 2017 /PRNewswire/ -- Bayer announced today that the latest research from across its growing oncology portfolio will be presented at the 53rd Annual Meeting of the American...

Events [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Nextera Communications

Nextera is a privately owned Norwegian biotech company. Our approach is to manipulate the disease at the initiation of the escalating immune cascade by identifying and subsequentl...

Ultimovacs AS

Ultimovacs AS ('Ultimovacs') was established by Inven2 in 2011. The company's goal is to develop technology from the Norwegian Radium Hospital for use in cancer treatment and to m...

Targovax

Targovax was started in October 2010 to develop TG01, a vaccine targeting pancreatic cancer. TG01 is based on research from The Radium Hospital and Norsk Hydro in the end of the 9...

Axiall Corporation

Axiall Corporation is a leading integrated chemicals and building products company. It is an international manufacturer of chlor-alkali and derivatives, chlorovinyls and aromatics...

Clinical Trials [32 Associated Clinical Trials listed on BioPortfolio]

Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC

This research study is studying the safety and tolerability of an investigational combination of drugs, radium-223 plus pembrolizumab as a possible treatment for castration-resistant prost...

Radium Ra 223 Dichloride and Niraparib in Treating Patients With Hormone- Resistant Prostate Cancer Metastatic to the Bone

This phase Ib trial studies the side effects and best dose of niraparib when given together with radium Ra223 dichloride in treating patients with prostate cancer that keeps growing even w...

Metabolic Change in Prostate Cancer Bone Metastases on 68Ga-HBED-CC-PSMA (DKFZ-11) PET/CT Following Radium-223 Therapy

Broadly, the objective of this study is to evaluate the fractional decline of intensity of tracer uptake measured by SUVmax on 68Ga-PSMA PET/CT in bone metastases from prostate cancer foll...

Value of FLT PET/CT in Radium-223 Therapy of mCRPC Patients

The aim of the study is to investigate whether positron emission tomography (PET) using the tracer 18F-Fluorothymidine (FLT) can provide information on proliferative activity in bone marro...

A Phase II Clinical Trial of Radium-223 Activity in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) With Asymptomatic Progression While on Abiraterone Acetate or Enzalutamide Besides AR-V7 Mutational Status (EXCAAPE)

Radium-223 is indicated for the treatment of patients with mCRPC with symptomatic bone metastases and no known visceral metastatic disease. However, very few data have been reported in pat...

Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223

This is a prospective biomarker study on prostate cancer patients receiving Radium 223 as standard of care. Participants will take part in this research study because they have chosen Rad...

uPAR PET/CT in Radium-223-dichloride Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

The purpose of this study is to investigate the applicability of urokinase plasminogen activator receptor (uPAR) Positron Emission Tomography (PET) / CT molecular imaging in patients with ...

Study Testing Radium-223 Dichloride in Relapsed Multiple Myeloma

This study will be conducted in 2 parts. The phase 1b part will be an international, phase 1b, open-label, dose-escalation assessment of radium-223 dichloride administered with bortezomib ...

Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)

The purpose of this study is to determine the clinical benefits of using a rapidly cycling, non-cross reactive regimen of FDA-approved prostate cancer therapeutic agents in the management ...

Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO) in RCC Patients With Bone Metastases. (EIFFEL)

This is a prospective, multicentre, open-label, phase I/II study to evaluate the maximum tolerated dose (MTD), and the most successful dose (MSD) of XOFIGO®, in renal cancer patients with...

PubMed Articles [52 Associated PubMed Articles listed on BioPortfolio]

Phosgene-induced acute lung injury (ALI): differences from chlorine-induced ALI and attempts to translate toxicology to clinical medicine.

Phosgene (carbonyl dichloride) gas is an indispensable chemical inter-mediate used in numerous industrial processes. There is no clear consensus as to its time- and inhaled-dose-dependent etiopatholog...

Photoinduced electron transfer across an organic molecular wall: octa acid encapsulated ESIPT dyes as electron donors.

Efficient photoinduced electron transfer from proton transfer dyes encapsulated within water soluble supramolecular host octa acid to electron acceptors present outside the capsule was observed in aqu...

Therapies for castration-resistant prostate cancer in a new era: The indication of vintage hormonal therapy, chemotherapy and the new medicines.

When advanced prostate cancer recurred during hormonal therapy and became the castration-resistant prostate cancer, "vintage hormonal therapy," such as antiandrogen alternating therapy or estrogen-rel...

223Ra-dichloride response in a patient with Paget disease and bone metastases secondary to castration-resistant prostate cancer.

Paget disease is commonly asymptomatic and discovered when an imaging test is performed for another clinical indication or when elevated serum alkaline phosphatase is found. Bone pain usually appears ...

Experimental outgassing of toxic chemicals to simulate the characteristics of hazards tainting globally shipped products.

Ambient monitoring analyses may identify potential new public health hazards such as residual levels of fumigants and industrial chemicals off gassing from products and goods shipped globally. We anal...

Mapping natural radioactivity of soil samples in different regions of Punjab, India.

Thallium activated sodium iodide (NaI(Tl)) detector and multi channel analyzer has been utilized to measure gamma rays emitted by radio nuclides found in soil samples of south-west (SW) region of Punj...

Appraisal of levels and patterns of occupational exposure to 1,3-butadiene.

Objectives 1,3-butadiene is classified as carcinogenic to human by inhalation and the association with leukemia has been observed in several epidemiological studies. The aim of this study was to evalu...

Mechanisms of resistance to systemic therapy in metastatic castration-resistant prostate cancer.

Patients with metastatic castration-resistant prostate cancer (mCPRC) now have an unprecedented number of approved treatment options, including chemotherapies (docetaxel, cabazitaxel), androgen recept...

Monitoring of treatment for metastatic castration-resistant prostate cancer.

Treatments currently available for metastatic castration-resistant prostate cancer (mCRPC) include abiraterone acetate, enzalutamide, docetaxel, cabazitaxel, and radium-223. However, the optimal seq...

Potential mechanisms of development-dependent adverse effects of the herbicide paraquat in 3D rat brain cell cultures.

Exposure to environmental toxicants during vulnerable windows of brain development is suspected to raise the prevalence for neurological dysfunctions at later stages in life. Differentiation processes...

Videos

None available.

Medical and Biotech [MESH] Definitions

Radium. A radioactive element of the alkaline earth series of metals. It has the atomic symbol Ra, atomic number 88, and atomic weight 226. Radium is the product of the disintegration of uranium and is present in pitchblende and all ores containing uranium. It is used clinically as a source of beta and gamma-rays in radiotherapy, particularly BRACHYTHERAPY.

1,1'-Bis(phenylmethyl)4,4'-bipyridinium dichloride. Oxidation-reduction indicator.

Radon. A naturally radioactive element with atomic symbol Rn, atomic number 86, and atomic weight 222. It is a member of the noble gas family and released during the decay of radium and found in soil. There is a link between exposure to radon and lung cancer.

Therapeutic practices which are not currently considered an integral part of conventional allopathic medical practice. They may lack biomedical explanations but as they become better researched some (PHYSICAL THERAPY MODALITIES; DIET; ACUPUNCTURE) become widely accepted whereas others (humors, radium therapy) quietly fade away, yet are important historical footnotes. Therapies are termed as Complementary when used in addition to conventional treatments and as Alternative when used instead of conventional treatment.

Quick Search
Advertisement
 

Relevant Topics

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

review and buy Xofigo (radium-223 dichloride) market research data and corporate reports here

Channels Quicklinks